创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

KAN Shaoxin, LU Na. Advances in the Research on Cyclin-dependent Kinase 9 and Its Inhibitors[J]. Progress in Pharmaceutical Sciences, 2020, 44(3): 208-214.
Citation: KAN Shaoxin, LU Na. Advances in the Research on Cyclin-dependent Kinase 9 and Its Inhibitors[J]. Progress in Pharmaceutical Sciences, 2020, 44(3): 208-214.

Advances in the Research on Cyclin-dependent Kinase 9 and Its Inhibitors

  • Cyclin-dependent kinases (CDKs) are not only responsible for cell cycle regulation in cells, but also play an important role as regulators in cell transcription. CDK9, a member of the CDKs family, plays an important role in cellular transcriptional regulation. CDK9 associates mainly with Cyclin T1 and forms the positive transcription elongation factor b (P-TEFb), which regulates the transcription elongation by phosphorylating the carbon-terminal domain (CTD) of RNA polymerase Ⅱ (Pol II). CDK9 inhibitors inhibit CDK9-mediated transcriptional extension by competitive binding. This review briefly introduces the functions of CDK9 and its mechanisms of action in tumor, and summarizes the progress in the study of CDK9 inhibitors.
  • loading

Catalog

    Turn off MathJax
    Article Contents

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return